COVID-19 infection
Metadata
| Name | COVID-19 infection |
| Type | Disease or Syndrome |
| Group | COVID-19 infection |
| Data Sources |
|
| Clinical Terminologies |
SNOMED-CT ICD-10 |
| Codelists | |
| Valid Event Data Range | 01/01/2020 - 31/10/2020 |
| Sex |
Female Male |
| Authors | BHF CVD COVID UK Consortium |
| Agreement Date | 31 Oct 2020 |
| Version (UUID) | Revision 1 (83NbVPhy532ogkJrxzUmoy) |
Primary Care
| conceptId | term | type |
|---|---|---|
| 1300721000000109 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (situation) | 1 |
| 1240751000000100 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1240581000000104 | Severe acute respiratory syndrome coronavirus 2 ribonucleic acid detected (finding) | 1 |
| 1008541000000105 | Coronavirus ribonucleic acid detection assay (observable entity) | 1 |
| 186747009 | Coronavirus infection (disorder) | 1 |
| 1300731000000106 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed using clinical diagnostic criteria (situation) | 1 |
| 1240511000000106 | Detection of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction technique (procedure) | 1 |
| 1240551000000105 | Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1240741000000103 | Severe acute respiratory syndrome coronavirus 2 serology (observable entity) | 1 |
| 1300681000000102 | Assessment using coronavirus disease 19 severity scale (procedure) | 1 |
| 1300631000000101 | Coronavirus disease 19 severity score (observable entity) | 1 |
| 1321541000000108 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin G detected (finding) | 1 |
| 1240541000000107 | Infection of upper respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1029481000000103 | Coronavirus nucleic acid detection assay (observable entity) | 1 |
| 1300671000000104 | Coronavirus disease 19 severity scale (assessment scale) | 1 |
| 1321551000000106 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin M detected (finding) | 1 |
| 1240401000000105 | Antibody to severe acute respiratory syndrome coronavirus 2 (substance) | 1 |
| 1240421000000101 | Serotype severe acute respiratory syndrome coronavirus 2 (qualifier value) | 1 |
| 1240571000000101 | Gastroenteritis caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1321331000000107 | Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 total immunoglobulin in serum (observable entity) | 1 |
| 1321761000000103 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin A detected (finding) | 1 |
| 1322871000000109 | Severe acute respiratory syndrome coronavirus 2 antibody detection result positive (finding) | 1 |
| 1240391000000107 | Antigen of severe acute respiratory syndrome coronavirus 2 (substance) | 1 |
| 1240531000000103 | Myocarditis caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1321341000000103 | Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin G in serum (observable entity) | 1 |
| 1322781000000102 | Severe acute respiratory syndrome coronavirus 2 antigen detection result positive (finding) | 1 |
| 1240521000000100 | Otitis media caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1321321000000105 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin G qualitative existence in specimen (observable entity) | 1 |
| 1240561000000108 | Encephalopathy caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1321241000000105 | Cardiomyopathy caused by severe acute respiratory syndrome coronavirus 2 (disorder) | 1 |
| 1321201000000107 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 health issues simple reference set (foundation metadata concept) | 1 |
| 1321301000000101 | Severe acute respiratory syndrome coronavirus 2 ribonucleic acid qualitative existence in specimen (observable entity) | 1 |
| 1321311000000104 | Severe acute respiratory syndrome coronavirus 2 immunoglobulin M qualitative existence in specimen (observable entity) | 1 |
| 120814005 | Coronavirus antibody (substance) | 1 |
| 1321181000000108 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 record extraction simple reference set (foundation metadata concept) | 1 |
| 1321351000000100 | Arbitrary concentration of severe acute respiratory syndrome coronavirus 2 immunoglobulin M in serum (observable entity) | 1 |
| 1321191000000105 | Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 procedures simple reference set (foundation metadata concept) | 1 |
Hospitalizations
| icd10code | icd10term | type |
|---|---|---|
| U071 | COVID-19, virus identified | 1 |
| U072 | COVID-19, virus not identified | 1 |
Implementation
We ascertained people with a confirmed or suspected Covid-19 diagnosis as follows:
1) a positive PCR or antigen test from the Covid-19 laboratory test data, with specimen date on or before 31 October 2020; or
2) a Covid-19 diagnosis SNOMED-CT concept code appearing in the primary care data, with event date on or before 31 October; or
3) a diagnosis ICD-10 code appearing in the hospital episodes (main or secondary diagnostic code position in the admitted patient care component of the hospital episode statistics), with admission date on or before 31 October or
4) death registration with a mention (as underlying on contributing cause) of a diagnosis ICD-10 code , with death registration date on or before 31 October 2020.